Our top pick for
Beginners

Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Sonendo Inc is a medical devices business based in the US. Sonendo shares (SONX) are listed on the NYSE and all prices are listed in US Dollars. Sonendo employs 219 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Active traders
Latest market close | $1.72 |
---|---|
52-week range | $1.67 - $12.24 |
50-day moving average | $2.53 |
200-day moving average | $5.37 |
Wall St. target price | $6.28 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-4.43 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.72 from 2022-07-05
1 week (2022-06-30) | 1.72 |
---|---|
1 month (2022-06-07) | -29.80% |
3 months (2022-04-07) | -42.09% |
6 months (2022-01-07) | -69.45% |
1 year (2021-07-03) | N/A |
---|---|
2 years (2020-07-03) | N/A |
3 years (2019-07-03) | N/A |
5 years (2017-07-03) | N/A |
Revenue TTM | $34.8 million |
---|---|
Gross profit TTM | $8.3 million |
Return on assets TTM | -40.36% |
Return on equity TTM | -124.06% |
Profit margin | -152.62% |
Book value | $2.20 |
Market capitalisation | $47.3 million |
TTM: trailing 12 months
We're not expecting Sonendo to pay a dividend over the next 12 months.
You may also wish to consider:
Sonendo, Inc. , a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011.
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.